AZD6234
SELENE-Asia
AstraZeneca · Phase 3 · Not yet recruiting · Enrollment 330
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| AZD6234 Higher Target-Dose | n/r | n/r | n/r | n/r | n/r |
| AZD6234 Lower Target-Dose | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.